# BLENREP
> **BLA761440** · Biologics License Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 2025-10-23
## Drug
- **FDA Application Number:** BLA761440
- **Application type:** Biologics License Application
- **Brand name:** BLENREP
- **Generic name:** BELANTAMAB MAFODOTIN
- **Active ingredients:** BELANTAMAB MAFODOTIN-BLMF
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE LLC
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2025-10-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761440)
---
*MORVS · CC0 1.0*